Suchergebnisse - "Ciani, O"

PubPharm (14)

1

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

in: Cancer Management and Research | 2021

von Lux MP | Ciani O | Dunlop WCN | +2

2

The rise of rules : Will the new EU regulation of medical devices make us safer?

enthalten in: European journal of internal medicine | 2020

von Tarricone, R. | Ciani, O. | D'Acunto, S. | +1

3

Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer

enthalten in: Cancer epidemiology | 2020

von Elia, E. | Städler, N. | Ciani, O. | +2

4

European diabetes research and its funding, 2002-2013

enthalten in: Diabetic medicine : a journal of the British Diabetic Association | 2017

von Begum, M. | Lewison, G. | Sommariva, S. | +3

CommentIn: Diabet Med. 2017 Oct;34(10 ):1331. - PMID 28921715

5

European diabetes research and its funding, 2002–2013

enthalten in: Diabetic medicine | 2017

von Begum, M. | Lewison, G. | Sommariva, S. | +3

6

Decision Uncertainty and Need for Further Research: A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

enthalten in: Value in health | 2016

von Ciani, O. | Epstein, D. | Rothery, C. | +2

7

146 Intravesical administration of combined hyaluronic acid and chondroitin sulphate vs standard of care for the treatment of female recurrent urinary tract infections (RUTIs): What did we learn from a multicentre European real life setting case-control study?

enthalten in: European urology / Supplements | 2015

von Ciani, O. | Arendsen, E. | Romancik, M. | +10

8

The role of health technology assessment bodies in shaping drug development

in: Drug Design, Development and Therapy | 2014

von Ciani O | Jommi C

9

Validation of Surrogate Endpoints in Advanced Solid Tumours: Systematic Review of Statistical Methods, Results, and Implications for Policy Makers

enthalten in: Value in health | 2013

von Ciani, O. | Davis, S. | Tappenden, P. | +6

10

Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses

enthalten in: Health economics | 2013

von Ciani, O. | Taylor, R.

CommentOn: Health Econ. 2012 Jun;21(6):742-56. - PMID 21796723